REGISTERED NUMBER: 02200154 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

SJK SCIENTIFICS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr S J Karmy

Mrs J Karmy

SECRETARY:

Mrs J Karmy

REGISTERED OFFICE:

Cheriton House

The Hop Gardens

Whiteparish

Salisbury

SP5 2SS

REGISTERED NUMBER:

02200154 (England and Wales)

ACCOUNTANTS:

Fawcetts LLP

Chartered Accountants

Windover House

St Ann Street

Salisbury

SP1 2DR

FIXED ASSETS

Tangible assets

4

177,743

177,743

Investments

5

1,044,116

1,187,468

1,221,859

1,365,211

CURRENT ASSETS

Debtors

6

5,259

7,651

Cash at bank and in hand

33,852

64,522

39,111

72,173

CREDITORS

Amounts falling due within one year

7

27,420

131,166

NET CURRENT ASSETS/(LIABILITIES)

11,691

(58,993

)

TOTAL ASSETS LESS CURRENT LIABILITIES

1,233,550

1,306,218

PROVISIONS FOR LIABILITIES

30,386

42,964

NET ASSETS

1,203,164

1,263,254

CAPITAL AND RESERVES

Called up share capital

8

100

100

Fair value reserve

9

91,157

128,893

Retained earnings

9

1,111,907

1,134,261

SHAREHOLDERS' FUNDS

1,203,164

1,263,254

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:

Dr S J Karmy - Director

1.	STATUTORY INFORMATION

SJK Scientifics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The financial statements are presented in Sterling (£) which is the functional currency of the company.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Turnover

Turnover represents net invoiced sales of goods and services, excluding value added tax.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

see below

Plant and machinery

-

20% on cost

Computer equipment

-

15% on cost

Freehold property which consists solely of land is not depreciated.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Investments

Investments are initially recorded at cost and subsequently recorded at fair value. Any changes to fair value are recognised in the profit and loss account.

Debtors

Debtors are measured at their recoverable amount.

Creditors and provisions

Creditors and provisions are recognised where the company has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discount due.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2024

and 31 March 2025

177,743

4,741

182,484

DEPRECIATION

At 1 April 2024

and 31 March 2025

-

4,741

4,741

NET BOOK VALUE

At 31 March 2025

177,743

-

177,743

At 31 March 2024

177,743

-

177,743

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1 April 2024

1,187,468

Additions

352,923

Disposals

(509,172

)

Revaluations

12,897

At 31 March 2025

1,044,116

NET BOOK VALUE

At 31 March 2025

1,044,116

At 31 March 2024

1,187,468

Cost or valuation at 31 March 2025 is represented by:

Other

investments

£

Valuation in 2022

213,018

Valuation in 2023

(110,989

)

Valuation in 2024

69,828

Valuation in 2025

12,897

Cost

859,362

1,044,116

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

-

3,663

Other debtors

5,259

3,988

5,259

7,651

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

425

1,438

Taxation and social security

10,783

5,844

Other creditors

16,212

123,884

27,420

131,166

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

75

"A" Ordinary

£1

75

75

25

"B" Ordinary

£1

25

25

100

100

Shares rank pari-passu in all respects.

9.

RESERVES

Fair

Retained

value

earnings

reserve

Totals

£

£

£

At 1 April 2024

1,134,261

128,893

1,263,154

Profit for the year

85,741

85,741

Dividends

(88,151

)

(88,151

)

Transfers

(19,944

)

(37,736

)

(57,680

)

At 31 March 2025

1,111,907

91,157

1,203,064

The fair value reserve is used to record unrealised gains in the value of investments and losses to the extent that such a loss relates to a previous gain on the same asset.

10.	RELATED PARTY DISCLOSURES

Creditors due within one year include £10,446 (2024 - £118,769) which is owed to the directors of the company.